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Gouw AM, Efe G, Barakat R, Preecha A, Mehdizadeh M, Garan SA,
Brooks GA. Roles of estrogen receptor-alpha in mediating life span: the hypotha-
lamic deregulation hypothesis. Physiol Genomics 49: 88–95, 2017. First published
December 23, 2016; doi:10.1152/physiolgenomics.00073.2016.—In several spe-
cies caloric restriction (CR) extends life span. In this paper we integrate data from
studies on CR and other sources to articulate the hypothalamic deregulation
hypothesis by which estrogen receptor-alpha (ER-!) signaling in the hypothalamus
and limbic system affects life span under the stress of CR in mammals. ER-! is one
of two principal estrogen-binding receptors differentially expressed in the
amygdala, hippocampus, and several key hypothalamic nuclei: the arcuate nucleus
(ARN), preoptic area (POA), ventromedial nucleus (VMN), antero ventral periven-
tricular nucleus (AVPV), paraventricular nucleus (PVN), supraoptic nucleus
(SON), and suprachiasmatic nucleus (SCN). Estradiol signaling via ER-! is
essential in basal level functioning of reproductive cycle, sexually receptive
behaviors, physiological stress responses, as well as sleep cycle, and other non-
sexual behaviors. When an organism is placed under long-term CR, which intro-
duces an external stress to this ER-! signaling, the reduction of ER-! expression
is attenuated over time in the hypothalamus. This review paper seeks to characterize
the downstream effects of ER-! in the hypothalamus and limbic system that affect
normal endocrine functioning.
estrogen receptor; hypothalamus; HPG axis; sexual dimorphism; sexual behavior;
stress response; circadian rhythms; limbic system; caloric restriction; longevity
THE HYPOTHALAMUS GOVERNS developmental processes in verte-
brates, including mammals, fish, birds, reptiles, and amphibi-
ans (8, 13, 15, 16, 39). While the precise mechanism by which
the hypothalamus contributes to development and aging is
unknown, multiple nuclei of the hypothalamus function to
modify organismal sensitivity to hormones for maintaining
cellular and systemic homeostasis throughout an organism’s
life span (4, 39). In conjunction with key endocrine glands,
such as the anterior pituitary, hormonal actions in various
hypothalamic nuclei ultimately produce characteristic effects
on somatic growth, aging, and longevity (36, 39, 56).
In this study, we seek to delineate the hypothalamic dereg-
ulation hypothesis of aging, in which the hypothalamus influ-
ences the process of aging and the onset of discrete develop-
mental phases. This hypothesis postulates that hypothalamic
hormonal sensitivity is enhanced under specific conditions,
such as chronic stress. Altered hypothalamic sensitivity is
implicated in the interruption of downstream communication
with key neuroendocrine centers in the brain as well as endo-
crine glands throughout the body. Altered hypothalamic sen-
sitivity to endocrine signals, in turn, results in a disruption of
regular autonomic and endocrine functioning of the hypothal-
amus, which ultimately leads to the phenotypic effects of
aging. Historically, studies show that one method of limiting
the aging process is through long-term caloric restriction (CR)
(14, 35, 50, 55). The hypothalamic deregulation hypothesis
provides an explanation as to how CR slows aging by prevent-
ing drastic changes in the sensitivity of hypothalamic nuclei to
various hormones, but most specifically estrogen.
Estrogen has two primary receptor types: estrogen receptors
(ER)-alpha (!) and -beta (") (40, 48). Extensive research has
shown that these receptor types function independently and are
distributed broadly yet specifically in several key regions/
nuclei of the hypothalamus and in the limbic system (45, 48).
In this paper, we have chosen to focus on the alpha receptor
subtype. Encoded by the gene estrogen receptor 1 (ESR1) in
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humans, ER-! is composed of three domains: a modulating
NH2-terminal domain, a DNA-binding domain, and a ligand-
binding COOH-terminal domain (40). To explain the hypotha-
lamic deregulation hypothesis, we will spend the remainder of
this paper focusing on the expression and functions of ER-! in
a number of hypothalamic nuclei and limbic regions. We apply
the principles of the hypothalamic deregulation hypothesis as a
means to speculate what the ultimate effects of CR on aging via
estrogen signaling may be.
There seem to be significant evolutionary implications of
long-term CR in aging via ER-! in the hypothalamus and
limbic system. In this review, we aim to compile the results of
previous studies in the field of aging research. From these data,
we propose that unique signaling pathways have evolved in
several species as a result of changing food conditions. Our
hypothesis is congruent with the idea that these pathways grant
organisms the ability to alternate between normal and low food
availability, ultimately allowing them to survive (50). Results
of selected studies will be discussed in the context of such
evolutionary implications. Components of our hypothalamic
deregulation hypothesis along with experimental results are
presented sequentially (Fig. 1).
Localized Control of Reproduction
ER-! signaling in the arcuate nucleus (ARN) and the pre-
optic area (POA) is primarily responsible for controlling re-
productive function (45, 46, 58). More specifically, ER-! acts
to facilitate normal menstrual/estrous cycle through the homeo-
stasis of various sex hormones such as gonadotropin releasing
hormone (GnRH) and luteinizing hormone (LH) (46). Disrup-
tion of ER-! signaling results in decreased LH surge during
estrous cycle. ARN and POA interactions are accomplished
through transsynaptic communication between estrogen-sensi-
tive ER-! neurons in the ARN and GnRH-producing neurons
in the POA (46). ER-! knockout in the mouse ARN causes
acyclicity, rendering the mice in constant estrous cycle (58).
These observations show the crucial function of ER-! expres-
sion in the rostral ARN in maintaining cyclicity and estrogen-
dependent negative feedback. Thus ARN and POA ER-!
expression regulates GnRH production to maintain normal
endocrine reproductive function.
In addition to projections from select ER-! expressing
neurons in the ARN, strong afferent projections appear to
extend from the medial preoptic area (MPOA) to GnRH-
producing neurons in the rostral POA. These neurons are thus
implicated, along with other projecting neurons from the ARN,
in the control of downstream GnRH production (46). Similar
studies indicate that ER-! is coexpressed directly with GnRH-
producing neurons in the POA, providing the strong possibility
of a direct control of GnRH production via ER-! (5).
Other than manipulating expression of GnRH and LH,
estrogen may also collaborate with other factors to act directly
on GABAergic neurons in the POA via estrogen receptor
coexpression on these neurons as a means of controlling
negative feedback related to estrogen (25). In addition, several
prolactin-producing neurons in the brain, including neurons in
the ARN, express ER-! mRNA. It is hypothesized that estro-
gen regulation of prolactin production is likely achieved
through posttranscriptional mechanisms (20). ER-! has also
been shown to be strongly coexpressed with kisspeptin-ex-
pressing cells (kp10ir cells) in the caudate arcuate nucleus of
the mouse hypothalamus. Similar to ER-!, kisspeptins are
known to induce downstream production of GnRH and LH
(19). Thus manipulation of GnRH and LH can be influenced by
ER-! also via other factors such as GABA and prolactin.
CR has been known to preserve ER-! expression in the
hypothalamus. It may initially seem counterintuitive to main-
tain reproductive function during CR. From a perspective of
teleology, it may be supposed that if an animal is starving as
under CR, the reproductive pathways should be suppressed due
to the substantial energetic demands of pregnancy and child-
bearing. However, when reevaluated in terms of aging, ER-!
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Fig. 1. Hypothesized model of how via estrogen receptor alpha (ER-!) signaling stress mediates hypothalamic and limbic system functioning to affect somatic
health in aging.
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preservation may make sense from the perspective of long-
term animal survival. To the extent that CR extends life span,
extension of an organism’s reproductive functions would be a
favorable outcome. From this, it is reasonable to suspect that
extension of fecundity and overall life span during conditions
of CR, via ER-! preservation in the hypothalamus, is likely
evolutionarily selected.
Sexual Dimorphism, Sexual, Maternal, and Social Behaviors
ER-! signaling in the ARN and POA, as well as the
ventromedial nucleus (VMN) and anteroventral paraven-
tricular nucleus (AVPN) is primarily responsible for mod-
ulating sexual and social behaviors and determining differ-
ential developmental organization of neural circuitry be-
tween males and females (41).
Sexual dimorphism in ER-! expression. Studies have shown
sexually dimorphic increased ER-! expression that correlates
with Kiss1 expression in virtually all Kiss1-expressing hypo-
thalamic regions in the female rat brain (AVPV, MPOA, and
ARC) (19). In contrast, male rats had significantly greater
ER-" expression in the AVPV at birth, but this then changes in
adult age where female ER-" expression exceeds that in males.
Kiss1 expression especially in the ARC was found to be the
key regulatory factor in sexually dimorphic expression of ER-!
in the neonatal brain (8, 57).
Such sexually dimorphic ER-! induction has been shown
due to differential sexual hormone levels. Postnatal prairie
voles treated with oxytocin showed that by the age of 3 wk
female voles exhibited an increase of ER-! in the ventral
lateral septum (LSV), ventromedial hypothalamus (VMH) and
the central amygdala. Other areas, such as the MPOA, medial
amygdala (MeA) or ARC did not exhibit any apparent treat-
ment effects in either males or females (57). It was shown that
oxytocin has organizational effects on ER-! expression that are
sexually dimorphic. Early treatment of oxytocin induces ER-!
expression, yet inhibition of oxytocin in adult age causes
distinct reduction in ER-! differentially in males and females
(57). The organizational effects of estradiol within the AVPV
results in modest sex differences between male and female vole
development.
Besides prairie voles, sexually dimorphic regulation of ER-!
is also found in other rodents. For example, male and female
rats naturally express different levels of ER-! in different parts
of the hypothalamus partly due to the inhibition by testosterone
in male rats (26). Thus, there are multiple pathways that
contribute to the sexually dimorphic expression of ER-!.
A sexual dimorphic phenomenon also influences circadian
rhythm. Estrogens appear to act directly on neurons of the
circadian clock in suprachiasmatic nucleus (SCN) neurons.
The levels of expression appear to be sexually dimorphic, with
higher expression of ER-! in females than in males (29).
Coexpression of ER-! and ER-" has been found in neurons
and astrocytes of the SCN. Furthermore, estrogen receptor
coexpression with GABAergic neurons suggests that the mech-
anism of estradiol signaling in the SCN may be mediated by
this GABAergic signaling (48).
Sexual dimorphism of ER-! expression may suggest that CR
differentially extends life span in males vs. females (26, 29, 48,
57). It could be the case that the higher expression of ER-! in
females, which is preserved under CR, extends life span in
females when compared with males. One could speculate that
sexual dimorphism of ER-! expression may contribute to the
well-known epidemiological data that show longer average life
spans for women than men.
Sexual and maternal behaviors. The aforementioned sexual
dimorphic ER-! expression in the hypothalamus gives rise to
female sexual and parental behaviors that are less prominent in
males. Inhibition of ER-! signaling results in decreased rodent
maternal behaviors such as licking and grooming. The MPOA
in female rodents plays a significant role in controlling mater-
nal behaviors. In POA neurons, siRNA knockdown of ER-!
reduced characteristic maternal behaviors and increased ag-
gression toward sexual partners/intruders. These observations
demonstrate a crucial and significant role of POA-localized
ER-! in maintaining maternal behaviors (41).
In female rodents, it is well known that increased ER-!
expression in the ventrolateral ventromedial nucleus (vlVMN),
ARN, and MPOA corresponds to increased sexual behaviors
and sexual receptivity to a male (7, 44, 47). First, ARN ER-!
increases sexual receptivity in female rodents. ER-! forms a
complex with metabotropic glutamate receptor (mGluR1a),
ultimately allowing for the completion of signaling of the
lordosis circuit (10). Second, in the vlVMN ER-! increases
grooming and nurturing behavior. What a female rat experi-
ences from its mother can affect ER-! expression in their
vlVMN. Low grooming/nurturing offspring exhibited lower
ER-! expression (7). Third, ER-! expression in the MPOA of
primiparous rats may determine their ability to recover from
postpartum anxiety and depression. An increase in ER-! ex-
pression in the MPOA of primiparous rats 10 wk postpartum
coincided with a recovery from anxiogenic and depressive
responses (21). Thus it seems that ER-! expression in vlVMN,
ARN, and MPOA has various sexual and maternal behavioral
effects in female rodents.
Though less prominent, male mice are also affected by
hypothalamic ER-! expression. It has been shown that
sexual behaviors and aggressive behaviors are governed by
estradiol-organized circuitry in the MPOA and the VMH in
male mice (44). Knockdown of ER-! expression in the
VMH reduced both types of behaviors, whereas knockdown
in the MPOA resulted only in a reduction of sexual behav-
iors (44). This phenotype is also seen in female mice, where
knockout of ER-! in vlVMN results in increased aggression
toward juveniles. Aggressive behaviors appear to be at least
partially governed by estrogenic signaling via ER-! in the
VMN (47).
The aforementioned studies indicate that ER-! not only
hormonally increases fecundity via GnRH and LH, but that
ER-! also promotes the mating and nurturing behaviors that
would be necessary for successful reproduction (7, 10, 21, 44).
In addition, such positive behaviors are accompanied with
reduction of aggressive behaviors toward their mates and
juveniles. Though such behavioral changes are mostly in fe-
males, similar behavioral changes can be seen in males as well.
Overall, results are consistent with the notion that when CR
extends aging, CR also promotes sustained mating and nurtur-
ing behaviors that would enable successful reproduction even
in old age (7, 10, 21, 44, 47). This lends additional support to
the notion that despite reduced fecundity, CR extends the
window for reproduction, through the preservation of the ER-!
signaling in the hypothalamus.
90 HYPOTHALAMIC DEREGULATION HYPOTHESIS AND LIFE SPAN
Physiol Genomics • doi:10.1152/physiolgenomics.00073.2016 • www.physiolgenomics.org
 by 10.220.33.3 on June 7, 2017
http://physiolgenom
ics.physiology.org/
Downloaded from
 
Stress Response and the Hypothalamic-Pituitary-Adrenal
Axis
ER-! signaling in the paraventricular and supraoptic
nuclei (PVN and SON) is primarily responsible for control-
ling an organism’s response to physiological and environ-
mental stressors, such as osmotic stress, hunger, and acti-
vation of the hypothalamic-pituitary-adrenal axis (HPA
axis) (24, 50, 55, 56).
Estradiol signaling via ER-! in the PVN has been shown to
affect the HPA axis. Where older rodents show a decrease in
glucocorticoid receptors, estrogen treatment restores them. As
a result, ER-! restores the HPA feedback loop in the presence
of stressors (13). A correlative study determined that estrogen
likely acts directly on corticotropin releasing hormone (CRH)-
producing neurons in the PVN to affect the HPA axis (1, 6). It
has been shown that reproductive experience in female rodents
can determine the level of ER-! activation in regions such as
the PVN and the gene expression of CRH in response to
stressful circumstances, such as a maze test (6). Moreover,
increased ER-! expression (in PVN, not SON) combats effects
of osmotic stress (24). These findings are consistent with what
is seen in humans. There is an inverse correlation between
CRH and ER-! neurons in postmortem test subjects that
suffered from mood disorders such as depression or bipolar
disorder (1).
In addition to modulating the HPA axis, ER-! and -" are
responsible for controlling the nitric oxide (NO) metabolism in
the SON and PVN under basal conditions. Nitric oxide is
produced by hypothalamic neurons upon osmotic stress. How-
ever, under acute osmotic stress situations (i.e., NaCl admin-
istration), NO-producing neurons are drastically reduced, es-
pecially in the SON and PVN. However, an increase of ER-!
upon administration of ER-! agonists prevents the reduction of
NO-producing neurons in PVN and SON (24). The response to
osmotic stress demonstrates the neuroprotective roles of ER
against osmotic stress in the hypothalamus.
Studies on estradiol signaling via ER-! in the PVN could
indicate that ER-! has downstream effects stemming beyond
the reproductive system. ER-! is also implicated in modulating
the stress response. A naturally imposed CR diet results from
a lack of food; thus, one could posit that ER-! function is
preserved upon CR as a psychological self-defense mechanism
against the stress that comes with starvation. In other words,
the ability of ER-! signaling to overcome stress could be far
more directly linked to CR than previously thought. The
proreproductive functions of ER-! could simply be auxiliary
advantages that accompany CR, which ultimately contribute to
the increase in an organism’s fitness.
Circadian Rhythms in the SCN
The circadian pacemaker that regulates the sleep cycle as
well as biological rhythms of hormones and body temperature
is localized within the SCN. These SCN neurons contain ER-!,
ER-", and progesterone receptors. ER-! signaling in the SCN
is responsible for the regulation of clock gene expression and
communication with neighboring hypothalamic nuclei via af-
ferent synaptic connections to maintain time-regulated hor-
monal functioning (12).
In addition to ER-! and ER-" expression being directly
localized in the SCN, neurons afferent to the SCN projections
from the MPOA, the ARN, and the PVN also express ER-!
and ER-" (12). Hence, the pattern of ER isoform expression
provides further evidence for estrogenic signaling to the SCN
(12). Double label immunocytochemistry for ER-! and ER-"
and CtB (retrograde tracer cholera toxin B subunit) has shown
that estrogen regulates the circadian rhythm through steroid-
binding systems afferent to the SCN. This indicates that neu-
roanatomical pathways exist afferent to the SCN that mediate
effects of ER-! and ER-" on the circadian rhythm.
ER-! regulation of the circadian rhythm would be another
way by which CR promotes normal circadian functioning upon
aging (12). Dysfunctional SCN and disrupted circadian
rhythms are observed in older patients with dementia, as well
as in postmenopausal women (18, 39). More interestingly,
estradiol is able to restore normal SCN functioning in post-
menopausal women. Since disruption of circadian rhythm is
common in old age, increased ER-! and ER-" expression and
function would need to be preserved to allow for normal
circadian rhythmicity. As CR has been shown to extend life
span, we would expect CR individuals to have especially active
estrogen receptors in their phenotypes.
Expression in the Limbic System: ER-! Signaling in the
Hippocampus and Amygdala
In addition to broad ER-! expression within the aforemen-
tioned nuclei of the hypothalamus, estradiol signaling via ER-!
has also been observed in the limbic system, primarily in the
amygdala and the hippocampus (40). In the adult rat hippocam-
pus, ER-! expression is detected in the interneurons of the
dentate hilus polymorphic region, and in the CA1 stratum
radiatum (40). Since ER-! is also expressed in inhibitory
neurons of the CA1 region of the hippocampus, estradiol
signaling preserves neural plasticity of the hippocampus (40).
Like in the hypothalamus, ER-! has neuroprotective effects
in the hippocampus. Within the neurons of the hippocampus in
vitro, estrogens, including those that signal specifically through
ER-!, shield against glutamate toxicity, glucose deprivation,
FeSO4 toxicity, and amyloid-beta peptide toxicity, the last of
which contributes to Alzheimer’s disease (23). Learning and
memory in the hippocampus are preserved by the induction of
adult neurogenesis in the dentate gyrus, where both ER-! and
ER-" coexpression is found in ~80% of proliferating cells (34,
40). The generation of new neurons in the dentate gyrus via
estrogen signaling through ER-! may also be important for the
maintenance of hippocampal function and for adequate control
of the HPA axis (13).
Estradiol signaling via ER-! also cooperates with vesicular
glutamate transporter 2 (VGluT2)-expressing neurons in the
amygdala and the VMN (40). Coexpression of ER-! and
VGluT2 mediates the effects of estrogen on the rat medial
amygdala, the center of emotional responses to fear and anx-
iety (27). Social recognition and anxiety in female rats are
regulated by ER-! localized in this region (47).
The effect of CR on preservation of ER-! in the limbic
system appears to promote neural plasticity and fear regulation.
The prolonged neural plasticity and fear regulation in the
limbic system are consistent with the need to battle neurode-
generation and mood instability that are common in old age. In
extending life span, not only does CR prolong reproductive
functions and stress response abilities by preserving ER-!
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function in the hypothalamus, but ER-! preservation in the
limbic system prolongs neural plasticity and emotional regu-
lation.
ER-! Signaling and Its Effect on Aging: Effect of CR
In animal models of aging and CR, alterations in hypotha-
lamic sensitivity to peripheral hormones, particularly estrogen,
are known to influence the reproductive capabilities, matura-
tion, and senescence of an organism. Recent studies have
shown that the age-related reduction of total cells within the
ARC and POA of the hypothalamus, as well as ER-! immu-
noreactive cell populations in those regions, contribute to
normal aging (39). CR has been shown to have a protective
effect against this age-related cell loss by maintaining ER-!-
expressing cells (55). On average, CR has been shown to
attenuate the extensive ER-! immunoreactive cell loss by 31%,
helping maintain reproductive potential (55). This allows for
the maintenance of hormonal sensitivity in the hypothalamus,
thus aiding continued estrogen signaling and extending life
span (56).
Along with significantly slowing the onset of aging pheno-
types, CR has also been shown to reduce the onset of oocyte
loss accompanied with menopause and, in turn, decelerate
neural, reproductive aging processes as well as many other
physiological systems (39). In addition, protective capabilities
of CR in the maintenance of ER-!-expressing cells seem to
have profound evolutionary implications. According to the
hypothalamic dysregulation hypothesis, both puberty and ag-
ing are the products of alterations in hypothalamic sensitivity
to specific hormones like ER-!. CR extends reproductive life
span, which is considered the central evolutionary determinant
of total enhanced longevity (15, 18).
Despite the early experimental design problems of equating
ad libitum diet as normal diet long-term CR has been shown to
extend the life and health spans in laboratory-raised and
-housed organisms ranging from nonhuman primates and ro-
dents to invertebrates. However, results of studies on hy-
perphagic, caged mammals are discordant with current physi-
cal activity and dietary recommendations for healthful living
for humans. Hence, the absence of controlled, randomized
prospective studies on humans limits interpretation of CR
studies on nonhuman species for human populations (16, 22,
33, 35, 49).
Given the effects of CR on ER-! expression in various
hypothalamic nuclei, studies have sought for mechanistic links
between CR and ER-! expression. First, peroxisome prolifera-
tor activated receptor gamma coactivator-1! (PGC-1!) is
known to be a key regulator in glucose metabolism, cellular
respiration, energy production, and adaptive thermogenesis (9,
31, 54). Studies have shown that CR induces PGC-1! leading
to mitochondrial biogenesis and increased life-span (34, 42). In
vitro CR models, shows that CR elevates PGC-1! expression
and mitochondrial function (32). Furthermore, calorie-re-
stricted human subjects have increased levels of PGC-1! (30).
This is concomitant with studies that show PGC-1! as medi-
ator of AMP-activated protein kinase (AMPK), which regu-
lates mitochondrial biogenesis (30).
PGC-1! is also a coactivator of ER! on estrogen-responsive
element (ERE)-driven transactivity through the interaction of
carboxyl terminus of PGC-1 with the ER-! hinge domain (3,
28). Mitochondria biogenesis and energy production are in-
creased through the overexpression of PGC-1!. Several studies
report that PGC-1! can ameliorate mitochondrial dysfunctions
that are caused by certain age-related diseases including neu-
rodegenerative diseases (11). In vitro studies have shown that
PGC-1! elevates the estradiol-dependent transactivity of ER-!
(38). Thus PGC-1! seems to be the mechanism by which CR
induces ER-! expression, which leads to well-known neuro-
protective effects of CR in aging.
CR and Longevity in Humans
Having established the plausible mechanism between CR,
PGC-1!, and ER-! in aging, studies have shown that CR’s effects
on aging extends to humans as well (14, 50). CR studies on
humans have shown less age-associated phenomena such as
myocardial stiffness and autonomic dysfunction, as well as down-
regulation of the phosphoinositide 3-kinase (PI3K)/protein kinase
B (AKT)/forkhead box O (FOXO) and inflammatory pathways in
skeletal muscle (2). Consistent with the slow aging rodent models,
humans on CR also exhibit signs of slower aging with low levels
of inflammation due to low C-reactive protein and tumor necrosis
factor-alpha (TNF-!), decreased serum triiodothyronine levels,
and a more elastic and healthier left ventricle (4). Considering that
aging is marked by the development of disease, long-term CR in
humans has been shown to also support “slow aging” by increas-
ing the healthy life span and lowering the risk of many age-related
diseases such as cardiovascular disease, cancer, diabetes, neuro-
degenerative diseases, and several autoimmune disorders (14).
Reduction of body weight by CR in humans has been shown to
improve glucose tolerance and increases insulin sensitivity, while
also decreasing the risk of developing Type 2 diabetes, hyperten-
sion, coronary heart disease, dementia, breast cancer, prostate
cancer, and colon cancer (54). Similarly, CR has also been proven
to also protect normal cells and organs from toxic conditions
while promoting the death of cancer cells (4). The role of ER-!,
especially in breast cancer progression, has been shown as drug-
resistant cancer cells still have ER-chromatin occupancy but
acquired differential ER-binding profiles modulated by progester-
one receptor (PR), which can be linked to the effects of CR on
cancer (37, 43). Prolonged CR in humans also reduces two
biomarkers of longevity, which are fasting insulin level and body
temperature.
One novel insight into the effects of long-term CR in
humans stems from studies of the Okinawan population of
Japan who are renowned for their reduced morbidity and
mortality (14). While their diet is similar to those under CR, an
uncontrolled variable in the study was the level of physical
activity by Okinawans. Despite the difference in physical
activity level, the Okinawan life style resulted in a 50% lower
death rate between ages 60–64 yr than Americans, and a
30–40% lower death rate from heart disease, stroke, and
cancer than in other regions in Japan itself (14). The extension
of health and life spans seen in CR animal experiments mimics
the effects seen in the Okinawans (51–53).
Results from the Biosphere 2 experiment also proved the
health benefits of the CR diet. In 1991, eight subjects entered
Biosphere 2, a closed environment in an Arizona desert region.
There, those individuals maintained a CR diet for the duration
of 2 yr, and their physiological and biochemical responses
were monitored for 18 mo after returning to their normal diets
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(50). During CR, the eight individuals experience a lower
metabolic rate, body temperature, systolic and diastolic blood
pressure, and thyroid hormone levels. Despite weight loss, the
participants of this study remained in excellent health and
maintained high levels of physical and mental activity through-
out the entire 2 yr period (50). Regrettably, the investigators
did not include the cohort in which caloric control or physical
fitness were manipulated with exercise training; nonetheless,
they concluded that healthy nonobese humans on a CR diet
show physiological, hematological, hormonal, and biochemical
changes that are similar to those seen in in rodents and
nonhuman primates under CR (50).
In another study done by the Caloric Restriction Society, 18
volunteers practiced the CR diet for 3–15 yr, consuming
1,112–1,958 kcal/day, while age-matched and height-matched
controls consumed 1,976–3,537 kcal/day (14). The subjects
showed significant reductions in blood glucose levels, insulin
levels, and blood pressure (17). The 18 test subjects also
demonstrated reduced total cholesterol, low-density lipoprotein
(LDL), and triglycerides and increased high-density lipopro-
tein (HDL) compared with the controls (17). Another 6 mo
randomized clinical trial of overweight or obese premeno-
pausal women that fasted for 2 nonconsecutive days per week
showed similar results. In both studies, the CR group showed
a reduction of C-reactive protein and about a 40% reduction of
carotid artery intima-media thickness, thereby proving a re-
duced risk of atherosclerosis and cardiovascular disease (17).
Although CR may have the ability to increase the health
span in animal model systems, it does not come without risks
for humans. Results from the 1950 Minnesota Starvation Study
in which 36 physically and psychologically healthy men un-
derwent a 50% of normal dietary intake CR for 6 mo showed
that some individuals participating in a CR diet may experience
loss of libido, hypotension, menstrual irregularities, infertility,
and irritability (14). During CR, low estrogen levels could also
potentially lead to bone thinning or osteoporosis, while hor-
monal changes may lead to slower wound healing (14). Fur-
ther, obesity resulted in the post-CR period of the Minnesota
Starvation Study. For these reasons, the extent and long-term
effects of CR should be strongly considered when further
studying CR in humans.
Summary
In humans and rodent models, ER-! signaling occurs in the
different regions of the hypothalamus, namely the ARN, POA,
VMN, AVPV, PVN, SON, SCN, as well as the amygdala and
hippocampus of the limbic system. Throughout development,
nuclei of the hypothalamus function to maintain homeostasis
sensitivity of hypothalamic neurons to estradiol, affecting
growth and development and, ultimately, health and longevity
of the organism. In each hypothalamic and limbic brain region,
ER-! signaling plays a unique role with respect to the different
function of the nuclei/region itself. First, ER-! in the hypo-
thalamus, especially within the ARN and POA, controls repro-
ductive functioning by upregulating GnRH production. Sec-
ond, ER-! signaling centralized in the ARN, POA, VMN, and
AVPV nucleus modulates sexual and social behaviors. Third,
ER-! signaling in the POA is crucial to maintain maternal
behavior in females and paternal acceptance to parental care.
Fourth, within the SON and PVN, the ER-! signaling also
protects neurons from osmotic stress, which in turn strengthens
the HPA axis in handling stress. Fifth, within the SCN, ER-!
signaling is responsible for the regulation of clock genes such
as period circadian clock 2 (PER2) and maintenance of normal
circadian rhythm. Sixth, in the limbic system, ER-! expression
contributes to learning and memory through neurogenesis,
regulation of anxiety, neuroprotective effects against gluta-
mate, FeSO4, amyloid-" peptide toxicity, and glucose depri-
vation. Mechanistically, PGC1-!, AMPK, PI3K, AKT, and
FOXO have been implicated in mediating CR and ER-! effects
in promoting longevity.
Considering the critical role of ER-! expression in these
regions, disruption in ER-! sensitivity in any of these afore-
mentioned areas of the hypothalamus and limbic system would
be expected to produce significant effects to the health and
functioning of the organism itself, greatly contributing to the
overall longevity. As an evolutionary response to changing
environments, the effects of ER-! signaling have been posi-
tively selected to maximize their life span to create viable
offspring at the most appropriate time. In this paper, we
articulate the hypothalamic deregulation hypothesis by which
ER-! signaling and hypothalamic and limbic hormonal sensi-
tivity affect mammalian life span under specific stress condi-
tions, such as CR. In previous studies, CR has been shown to
maintain ER-!-expressing cells and to provide the stimulus to
impede changes in hormonal sensitivity, extending the repro-
ductive life span and consequently lengthening the total mam-
malian life span by delaying senescence. ER-! signaling main-
tains the normal functioning of the aforementioned hypotha-
lamic and limbic brain regions and consequently allows for the
prolonging of healthier conditions for the organism.
Currently, minimal research has been done on the effects of
CR within individual nuclei, as well as the evolutionary im-
plications for each of their individualized responses. In addi-
tion, lack of randomized, controlled prospective studies limits
translation of data from rodents and other animals to the human
condition, particularly because of the recommendations for
human diet and nutrition based on quality good clinical prac-
tice promoted by several professional medical and health-
promoting organizations. Nonetheless, ER-! regulation in the
regions of the hypothalamus and limbic system in relation to
CR continues to be an important area of research to further
understand the processes of normal aging and the implications
for improving human wellbeing.
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